scispace - formally typeset
M

Maria Luisa De Lodovici

Researcher at University of Insubria

Publications -  18
Citations -  645

Maria Luisa De Lodovici is an academic researcher from University of Insubria. The author has contributed to research in topics: Stroke & Atrial fibrillation. The author has an hindex of 10, co-authored 18 publications receiving 477 citations. Previous affiliations of Maria Luisa De Lodovici include Vita-Salute San Raffaele University.

Papers
More filters
Journal ArticleDOI

Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Effect of Anticoagulation and Its Timing: The RAF Study

Maurizio Paciaroni, +74 more
- 01 Aug 2015 - 
TL;DR: It is observed that high CHA2DS2-VASc score, high National Institutes of Health Stroke Scale, large ischemic lesions, and type of anticoagulant administered each independently led to a greater risk of recurrence and bleedings.
Journal ArticleDOI

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study

Maurizio Paciaroni, +81 more
TL;DR: Treatment with NOACs was associated with a combined 5% rate of ischemic embolic recurrence and severe bleeding within 90 days, and the optimal timing to administer non–vitamin K oral anticoagulants in patients with acute ischeic stroke and atrial fibrillation was unclear.
Journal ArticleDOI

Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature.

TL;DR: Thrombolysis is associated with a non-negligible incidence of major bleeding complications, including intracranial bleeding potentially affecting patients outcome, and future studies are necessary to evaluate the safety of thromboelsis in comparison to more conservative strategies.
Journal ArticleDOI

Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes

Maurizio Paciaroni, +104 more
TL;DR: In patients with HT, anticoagulation was initiated about 12 days later than patients without HT, and this delay was not associated with increased detection of ischemic recurrence, but HT was associated with increase mortality or disability.
Journal ArticleDOI

Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study

Maurizio Paciaroni, +74 more
- 01 Feb 2015 - 
TL;DR: Endovascular treatment of patients with acute ischemic stroke and extracranial ICA occlusion did not result in a better functional outcome than treatment with intravenous thrombolysis, but was associated with a higher rate of intracranial bleeding.